French registry confirms 3-Year results for breathing valve
Disease control
Completed
This French registry tracked 155 patients with severe emphysema who received the Zephyr Valve treatment. The goal was to collect long-term safety and effectiveness data over three years to support continued availability in France. Doctors followed patients for improvements in bre…
Sponsor: Pulmonx Corporation • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC